Home › Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety...
 

Keywords :   


Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety...

2015-02-27 16:20:00| Appliances - Topix.net

CAMBRIDGE, Mass. & STOCKHOLM-- -- Biogen Idec and Swedish Orphan Biovitrum AB today announced positive top-line results of the Kids B-LONG Phase 3 clinical study that evaluated the safety, efficacy and pharmacokinetics of ALPROLIXA [Coagulation Factor IX , Fc Fusion Protein] in children under age 12 with severe hemophilia B. ALPROLIX was generally well tolerated and no inhibitors were detected during the study.

Tags: positive safety announce efficacy

Category:Consumer Goods and Services

Latest from this category

All news
05.11PM responds to Sir Alan Bates after repeated requests
05.11Tube strikes called off after union talks
05.11NI rise hits workers harder than employers, says OBR
05.11Netflix Europe offices raided in tax fraud probe
05.11Vodafone-Three merger could get green light, watchdog says
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
Consumer Goods and Services »
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Delayed implementation of EID eartag rule requested
More »